Cite
HARVARD Citation
Correll, C. et al. (2022). Effectiveness and Safety of High‐Dose Biologics in Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance. Arthritis care & research. 74 (11), pp. 1770-1779. [Online].